...
首页> 外文期刊>Malaria Journal >Selective sweeps and genetic lineages of Plasmodium falciparum multi-drug resistance ( pfmdr1 ) gene in Kenya
【24h】

Selective sweeps and genetic lineages of Plasmodium falciparum multi-drug resistance ( pfmdr1 ) gene in Kenya

机译:肯尼亚恶性疟原虫多药耐药性(pfmdr1)基因的选择性扫描和遗传谱系

获取原文

摘要

Abstract BackgroundThere are concerns that resistance to artemisinin-based combination therapy might emerge in Kenya and sub-Saharan Africa (SSA) in the same pattern as was with chloroquine and sulfadoxine–pyrimethamine. Single nucleotide polymorphisms (SNPs) in critical alleles of pfmdr1 gene have been associated with resistance to artemisinin and its partner drugs. Microsatellite analysis of loci flanking genes associated with anti-malarial drug resistance has been used in defining the geographic origins, dissemination of resistant parasites and identifying regions in the genome that have been under selection.MethodsThis study set out to investigate evidence of selective sweep and genetic lineages in pfmdr1 genotypes associated with the use of artemether–lumefantrine (AL), as the first-line treatment in Kenya. Parasites (n?=?252) from different regions in Kenya were assayed for SNPs at codons 86, 184 and 1246 and typed for 7 neutral microsatellites and 13 microsatellites loci flanking (±?99?kb) pfmdr1 in Plasmodium falciparum infections.ResultsThe data showed differential site and region specific prevalence of SNPs associated with drug resistance in the pfmdr1 gene. The prevalence of pfmdr1 N86, 184F, and D1246 in western Kenya (Kisumu, Kericho and Kisii) compared to the coast of Kenya (Malindi) was 92.9% vs. 66.7%, 53.5% vs. to 24.2% and 96% vs. to 87.9%, respectively. The N F D haplotype which is consistent with AL selection was at 51% in western Kenya compared to 25% in coastal Kenya.ConclusionSelection pressures were observed to be different in different regions of Kenya, especially the western region compared to the coastal region. The data showed independent genetic lineages for all the pfmdr1 alleles. The evidence of soft sweeps in pfmdr1 observed varied in direction from one region to another. This is challenging for malaria control programs in SSA which clearly indicate effective malaria control policies should be based on the region and not at a country wide level.
机译:摘要背景有人担心,在肯尼亚和撒哈拉以南非洲(SSA)可能会以与氯喹和磺胺多辛-乙胺嘧啶相同的模式出现对基于青蒿素的联合治疗的耐药性。 pfmdr1基因的关键等位基因中的单核苷酸多态性(SNPs)与对青蒿素及其伙伴药物的耐药性有关。与抗疟疾药物抗性相关的基因座侧翼基因的微卫星分析已用于确定地理起源,抗药性寄生虫的传播以及鉴定基因组中正在选择的区域。 pfmdr1基因型中的血统与使用蒿甲醚-荧光粉(AL)有关,是肯尼亚的一线治疗。分析了肯尼亚不同地区的寄生虫(n?=?252)的86、184和1246密码子的SNPs,并对恶性疟原虫感染中7个中性微卫星和13个微卫星基因座(±99?kb)pfmdr1进行了分型。结果显示,pfmdr1基因中与耐药性相关的SNP的位点和区域特异性患病率不同。与肯尼亚海岸(马林迪)相比,肯尼亚西部(Kisumu,Kericho和Kisii)的pfmdr1 N86、184F和D1246患病率分别为92.9%,66.7%,53.5%,24.2%和96%。分别为87.9%。与AL选择相符的N F D单倍型在肯尼亚西部为51%,而在肯尼亚沿海为25%。结论在肯尼亚不同地区,特别是西部地区,与沿海地区相比,选择压力有所不同。数据显示所有pfmdr1等位基因具有独立的遗传谱系。从一个区域到另一个区域,观察到的pfmdr1软扫掠的证据方向不同。这对撒哈拉以南非洲地区的疟疾控制计划具有挑战性,该计划明确表明有效的疟疾控制政策应基于地区而不是全国范围。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号